发明名称 |
PREPARATION OF INTERMEDIATES OF X-RAY CONTRAST AGENTS |
摘要 |
The present invention relates to a process for the preparation of iodinated X-ray contrast agents and in particular to key intermediates thereof. It particularly relates to an improved process for preparation of 5-acetamido-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide (Compound A) or N,N′-bis(2,3-dihydroxypropyl)-5-formamido-2,4,6-triiodoisophthalamide (Compound C), which are intermediates in the industrial preparation of non-ionic X-ray contrast agents. More particularly the invention provides a process for deacylation of the acylated hydroxyl groups of an intermediate compound of Compound A and Compound C. |
申请公布号 |
US2015274645(A1) |
申请公布日期 |
2015.10.01 |
申请号 |
US201314437430 |
申请日期 |
2013.10.24 |
申请人 |
GE Healthcare AS |
发明人 |
Haaland Torfinn |
分类号 |
C07C237/46;A61K49/04;C07C231/14 |
主分类号 |
C07C237/46 |
代理机构 |
|
代理人 |
|
主权项 |
1. A process for preparation of an N-acylated monomeric compound selected from 5-acetamido-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide (Compound A) and N,N′-bis(2,3-dihydroxypropyl)-5-formamido-2,4,6-triiodoisophthalamide (Compound C) comprising a step wherein Compound B2,wherein each X individually denotes a hydrogen or an acyl group, provided that at least one of the X-groups attached to the nitrogen is an acyl group;is subjected to deacylation of the acylated hydroxyl groups by adding the Compound B2 to an aqueous solution of a deacylating agent. |
地址 |
Oslo NO |